Is Dabigatran As Effective As Warfarin on Cardiac Thrombus in a Patient With Atrial Fibrillation? A Challenging Question
| Autor: | Murat Sunbul, Ceyhun Mammadov, Altug Cincin, Bülent Mutlu |
|---|---|
| Rok vydání: | 2014 |
| Předmět: |
Male
medicine.medical_specialty 030204 cardiovascular system & hematology Antithrombins Dabigatran 03 medical and health sciences 0302 clinical medicine Internal medicine Atrial Fibrillation medicine Humans Pharmacology (medical) In patient cardiovascular diseases 030212 general & internal medicine Heart Atria Risk factor Stroke Pharmacology business.industry Warfarin Atrial fibrillation Thrombosis General Medicine Middle Aged medicine.disease Pulmonary embolism Treatment Outcome Cardiac thrombus cardiovascular system Cardiology business Pulmonary Embolism medicine.drug |
| Zdroj: | American journal of therapeutics. 23(3) |
| ISSN: | 1536-3686 |
| Popis: | Atrial fibrillation (AF) is an important risk factor for cardioembolic stroke. Warfarin is an effective treatment in reducing the risk of cardioembolic stroke in patients with AF. New anticoagulants have been widely using for stroke prophylaxis in patients with nonvalvular AF. Previous studies have suggested that thrombolytic therapy is effective treatment choice in patients with pulmonary embolisms. Warfarin therapy is also effective on prevention or treatment of cardiac thrombus in patients with AF. However, there are no evidence-based data on treatment of cardiac thrombus with new oral anticoagulants in patients with AF. In our case report, we reported an AF patient with cardiac thrombus and pulmonary embolism under dabigatran therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|